Hologic (FRA:HO1) EPS without NRI: €3.74 (TTM As of Dec. 2025)


FRA:HO1 Hologic Inc FRA:HO1
57 GF Score
Price €65.00
GF Value €70.17
! 5 Warning Signs
View Full Analysis

What is Hologic EPS without NRI?

Hologic FRA:HO1 57 EPS without NRI is €3.74 as of Dec. 2025. GuruFocus rates FRA:HO1 with a GF Score™ of 57/100 and a GF Value™ of €70.17. The stock has 5 warning signs investors should review.

Hologic's earnings per share without non-recurring items for the three months ended in Dec. 2025 was €0.89. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was €3.74.

During the past 12 months, Hologic's average earnings per share (NRI) Growth Rate was 3.60% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was -10.90% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was -6.20% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 12.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Hologic's EPS without NRI or its related term are showing as below:

FRA:HO1' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -63.7   Med: 28.25   Max: 232
Current: -10.9

During the past 13 years, Hologic's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 232.00% per year. The lowest was -63.70% per year. And the median was 28.25% per year.

FRA:HO1's 3-Year EPS without NRI Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 8.15 vs FRA:HO1: -10.90

Hologic's EPS (Diluted) for the three months ended in Dec. 2025 was €0.68. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.05.

Hologic's EPS (Basic) for the three months ended in Dec. 2025 was €0.68. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was €2.08.


Hologic  (FRA:HO1) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hologic EPS without NRI Related Terms


Hologic EPS without NRI Historical Data

* Premium members only.

The historical data trend for Hologic's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hologic EPS without NRI Chart

Hologic Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.15 6.08 3.71 3.68 3.63

Hologic Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.98 0.95 0.94 0.96 0.89

FRA:HO1 vs WST, COO, ALGN: EPS without NRI Comparison

For the Medical Instruments & Supplies subindustry, Hologic's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hologic PE Ratio without NRI vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Hologic's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Hologic's PE Ratio without NRI falls into.


FRA:HO1
57GF Score
Hologic Inc FRA:HO1
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hologic EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of €3.74 mean?
Hologic (FRA:HO1) has a EPS without NRI of €3.74 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Hologic and its competitors.
Is Hologic's EPS without NRI too high?
Hologic's current EPS without NRI is €3.74. Overall, Hologic has a GF Score™ of 57/100, reflecting its overall financial health beyond just this single metric.
How does Hologic's EPS without NRI compare to WST and COO?
Hologic's EPS without NRI of €3.74 can be compared against companies in the Medical Devices & Instruments industry. The industry median EPS without NRI is 8.15. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Medical Devices & Instruments company?
The median EPS without NRI among Medical Devices & Instruments companies is 8.15, based on 662 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Hologic and its competitors. For the Medical Devices & Instruments industry, the median EPS without NRI is 8.15 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hologic's current EPS without NRI is €3.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hologic stock overvalued right now?
Hologic (FRA:HO1) has a current EPS without NRI of €3.74. The stock's GF Value™ is €70.17, compared to a current price of €65.00 — trading 7.4% below its estimated fair value. The current EPS without NRI is €3.74. Hologic's overall GF Score™ is 57/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Hologic (FRA:HO1), the current EPS without NRI is €3.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hologic (FRA:HO1) Overvalued in 2026?

Based on GuruFocus' analysis, Hologic stock appears to be undervalued. The current stock price of €65.00 is trading 7.4% below its estimated GF Value™ of €70.17.

Key valuation signals for FRA:HO1:

  • EPS without NRI: €3.74
  • GF Value™: €70.17 vs. price of €65.00 (7.4% below fair value)
  • GF Score™: 57/100 with 5 warning signs

No single metric tells the full story. See the FRA:HO1 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hologic Business Description

Address 250 Campus Drive, Marlborough, MA, USA, 01752
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
57GF Score

Get the complete analysis for FRA:HO1

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price
€70.17
GF Value